Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Should hydroxyethyl starch be banned?

Roberts and colleagues’1 Correspondence in The Lancet asking WHO to support a ban on the use of hydroxyethyl starch (HES) deserves clarification. First, registration of HES is not yet suspended; a legally binding decision by the European Commission is still pending. Second, Roberts and colleagues claim that HES was used to treat postpartum haemorrhage in the WOMAN trial.2 In fact, the publication doesn’t provide any information about HES treatment or its related adverse events. Third, the authors refer to their own studies as examples of high-quality trials, but these have been publicly criticised for methodological deficiencies and severe limitations.